Acumapimod

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAcumapimod
Drug Alias NameAcumapimodum阿玛莫德阿库马莫德BCT-197BCT197A2201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitors
TargetsP38 mitogen-activated protein kinase
Therapy Area/IndicationsAcute Kidney InjuryPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMereo BiopharmaMereo Biopharma Group PlcNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsAcute Kidney InjuryPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A